DE60312494D1 - Optisch aktives pyridinderivat und medikament, das dieses enthält - Google Patents
Optisch aktives pyridinderivat und medikament, das dieses enthältInfo
- Publication number
- DE60312494D1 DE60312494D1 DE60312494T DE60312494T DE60312494D1 DE 60312494 D1 DE60312494 D1 DE 60312494D1 DE 60312494 T DE60312494 T DE 60312494T DE 60312494 T DE60312494 T DE 60312494T DE 60312494 D1 DE60312494 D1 DE 60312494D1
- Authority
- DE
- Germany
- Prior art keywords
- medicament
- optically active
- pyridine derivative
- active pyridine
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002070655A JP2003277383A (ja) | 2002-03-14 | 2002-03-14 | 光学活性ピリジン誘導体およびそれを含む医薬 |
JP2002070655 | 2002-03-14 | ||
PCT/EP2003/002169 WO2003076447A1 (en) | 2002-03-14 | 2003-03-03 | An optically acitve pyridine derivative and a medicament containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60312494D1 true DE60312494D1 (de) | 2007-04-26 |
DE60312494T2 DE60312494T2 (de) | 2007-11-29 |
Family
ID=27800344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60312494T Expired - Fee Related DE60312494T2 (de) | 2002-03-14 | 2003-03-03 | Optisch aktives pyridinderivat und medikament, das dieses enthält |
Country Status (13)
Country | Link |
---|---|
US (2) | US7375103B2 (de) |
EP (1) | EP1487842B1 (de) |
JP (2) | JP2003277383A (de) |
AR (1) | AR038950A1 (de) |
AU (1) | AU2003215624A1 (de) |
CA (1) | CA2478942A1 (de) |
DE (1) | DE60312494T2 (de) |
ES (1) | ES2283795T3 (de) |
HN (1) | HN2003000098A (de) |
PE (1) | PE20040242A1 (de) |
TW (1) | TW200403247A (de) |
UY (1) | UY27719A1 (de) |
WO (1) | WO2003076447A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005036655A1 (de) * | 2005-08-04 | 2007-02-08 | Bayer Healthcare Ag | Behandlung von Tumoren mit IKK-ß Inhibitoren |
US8426355B2 (en) | 2006-03-15 | 2013-04-23 | Theralogics, Inc. | Methods of treating muscular wasting diseases using NF-κB activation inhibitors |
WO2008044339A1 (fr) * | 2006-10-13 | 2008-04-17 | Aqumen Biopharmaceuticals K.K. | Agent thérapeutique/de prévention contenant un composé de statine, utilisé pour une maladie intraoculaire |
CN104491864A (zh) | 2008-04-21 | 2015-04-08 | 奥德纳米有限公司 | 用于治疗耳部疾病和病况的耳用调配物及方法 |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
AP2015008750A0 (en) * | 2013-04-08 | 2015-09-30 | Bayer Pharma AG | Use of substituted 2,3-dihydroimidazo[1,2-c] quinazolines for treating lymphomas |
US20180289685A1 (en) | 2015-04-30 | 2018-10-11 | Bayer Pharma Aktiengesellschaft | Combinations of inhibitors of irak4 with inhibitors of btk |
WO2017148902A1 (de) | 2016-03-03 | 2017-09-08 | Bayer Pharma Aktiengesellschaft | Neue 2-substituierte indazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
AU2017290256A1 (en) | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4272338B2 (ja) * | 2000-09-22 | 2009-06-03 | バイエル アクチェンゲゼルシャフト | ピリジン誘導体 |
-
2002
- 2002-03-14 JP JP2002070655A patent/JP2003277383A/ja active Pending
-
2003
- 2003-03-03 WO PCT/EP2003/002169 patent/WO2003076447A1/en active IP Right Grant
- 2003-03-03 JP JP2003574663A patent/JP2005526074A/ja active Pending
- 2003-03-03 ES ES03743829T patent/ES2283795T3/es not_active Expired - Lifetime
- 2003-03-03 DE DE60312494T patent/DE60312494T2/de not_active Expired - Fee Related
- 2003-03-03 US US10/508,107 patent/US7375103B2/en not_active Expired - Fee Related
- 2003-03-03 CA CA002478942A patent/CA2478942A1/en not_active Abandoned
- 2003-03-03 AU AU2003215624A patent/AU2003215624A1/en not_active Abandoned
- 2003-03-03 EP EP03743829A patent/EP1487842B1/de not_active Expired - Fee Related
- 2003-03-12 UY UY27719A patent/UY27719A1/es not_active Application Discontinuation
- 2003-03-12 AR ARP030100859A patent/AR038950A1/es not_active Application Discontinuation
- 2003-03-13 TW TW092105417A patent/TW200403247A/zh unknown
- 2003-03-13 HN HN2003000098A patent/HN2003000098A/es unknown
- 2003-03-13 PE PE2003000253A patent/PE20040242A1/es not_active Application Discontinuation
-
2008
- 2008-05-19 US US12/123,405 patent/US20090054424A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TW200403247A (en) | 2004-03-01 |
DE60312494T2 (de) | 2007-11-29 |
WO2003076447A1 (en) | 2003-09-18 |
JP2003277383A (ja) | 2003-10-02 |
HN2003000098A (es) | 2003-12-15 |
UY27719A1 (es) | 2003-10-31 |
EP1487842B1 (de) | 2007-03-14 |
US20050215547A1 (en) | 2005-09-29 |
EP1487842A1 (de) | 2004-12-22 |
JP2005526074A (ja) | 2005-09-02 |
PE20040242A1 (es) | 2004-05-15 |
AR038950A1 (es) | 2005-02-02 |
CA2478942A1 (en) | 2003-09-18 |
US7375103B2 (en) | 2008-05-20 |
ES2283795T3 (es) | 2007-11-01 |
AU2003215624A1 (en) | 2003-09-22 |
US20090054424A1 (en) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60328481D1 (de) | Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält | |
ATE483698T1 (de) | 5-(benz- (z) -yliden) -thiazolidin-4-onderivate als das immunsystem unterdrückende mittel | |
DE60336093D1 (de) | Selbstverschliessende Kanüle | |
DE60327230D1 (de) | Pentosezucker fermentierende zymomonas-stämme und verwendungen davon | |
DE60017716D1 (de) | Coextrudierte medizinische multilumenleitung | |
DE60324099D1 (de) | Arzneistoffhaltiger tampon | |
NO20052855D0 (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
NO20053224D0 (no) | Patient controlled drug administration device. | |
DE60308210D1 (de) | Medizinische fassvorrichtung | |
PT1500654E (pt) | Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos | |
FR2864080B1 (fr) | Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique | |
FR2843964B1 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
ATE479437T1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
MA28720B1 (fr) | Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique | |
FI20022225A0 (fi) | Sykerajan asettaminen sykemittarissa | |
MA27233A1 (fr) | Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique | |
DE60309169D1 (de) | Verwendung vom pullulan als langsam verdauliches kohlenhydrat | |
NO20050689L (no) | Terapeutisk anvendelse | |
FR2865205B1 (fr) | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique | |
DE60312494D1 (de) | Optisch aktives pyridinderivat und medikament, das dieses enthält | |
NL1024677A1 (nl) | Therapeutische prolinederivaten. | |
DE60016363D1 (de) | Aminoalkohol-Derivat und Medikament, das dieses Derivat enthält | |
DE60326734D1 (de) | Ligations-behandlungsgerät | |
FR2845388B1 (fr) | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique | |
FR2873693B1 (fr) | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE |
|
8339 | Ceased/non-payment of the annual fee |